Professor, Pathology, University of Pittsburgh School of Medicine
Pathology
Dr. Alan H. Wells, MD
|
|
Give Review
Dr. Alan H. Wells is an expert in the field of Pathology. He researched medicine at Warren Alpert Medical School of Brown University. He over the years received 1 awards: "Elected Member". Alan H. Wells, MD is a published doctor and has 21 publications published. The lastest was: 'CXCR3 in Carcinoma Progression.'
Publications
- CXCR3 in Carcinoma Progression.
- α-Actinin-4 Is Required for Amoeboid-type Invasiveness of Melanoma Cells.
- Engineering liver.
- Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system.
- A microphysiological system model of therapy for liver micrometastases.
- The Mitogen-activated Protein (MAP) Kinases p38 and Extracellular Signal-regulated Kinase (ERK) Are Involved in Hepatocyte-mediated Phenotypic Switching in Prostate Ca...
- Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.
- Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.
- Pericyte Regulation of Vascular Remodeling Through the CXC Receptor 3.
- The Dormancy Dilemma: Quiescence versus Balanced Proliferation.
- Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
- Targeting tumor cell motility as a strategy against invasion and metastasis.
- The matrikine Tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.
- Modeling boundary conditions for balanced proliferation in metastatic latency.
- Modeling the Assembly of the Multiple Domains of ?-actinin-4 and Its Role in Actin Cross-linking.
- Skin wound healing and scarring: fetal wounds and regenerative restitution.
- Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells.
- Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion.
- PKCδ Regulates Force Signaling during VEGF/CXCL4 Induced Dissociation of Endothelial Tubes.
- PKCδ Localization at the Membrane Increases Matrix Traction Force Dependent on PLCγ1/EGFR Signaling.
Schools
Brown University Alpert Medical School
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
Awards
- Elected Member
Education
-
University of California San Diego -
Warren Alpert Medical School of Brown University
Helpful Reviews
Similar Doctors
|
|
Dr. Michael J. Becich, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mark L. Bunker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gloria J. Carter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra S. Kaplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lirong Qu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce S. Rabin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Debra L. Zynger, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|